Fig. 6
From: NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses

(A) Correlation between NOX4 expression and tumor mutation burden (TMB). (B) Correlation between NOX4 expression and microsatellite instability (MSI).
From: NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses
(A) Correlation between NOX4 expression and tumor mutation burden (TMB). (B) Correlation between NOX4 expression and microsatellite instability (MSI).